electroCore,

electroCore, DSCR

The Debt Service Coverage Ratio (DSCR) of electroCore, (ECOR) as of Oct 20, 2026 is -0.87. In the previous year, Debt Service Coverage Ratio (DSCR) was -1.68 — a change of -48.17% (higher).

DSCR

-0.87

YoY

-48.17%

Last updated:

Debt Service Coverage Ratio (DSCR) of electroCore, is 2025 -0.87 . Debt Service Coverage Ratio (DSCR) of electroCore, was 2024 -1.68 . It decreases by -48.17% higher compared to the previous year.

The electroCore, DSCR history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

DSCR
Date
DSCR
Jan 1, 2016
-1.80 USD
Jan 1, 2019
-22.33 USD
Jan 1, 2020
-7.09 USD
Jan 1, 2021
-17.91 USD
Jan 1, 2022
-23.81 USD
Jan 1, 2023
-23.43 USD
Jan 1, 2024
-1.68 USD
Jan 1, 2025
-0.87 USD
The electroCore, DSCR history
YEARDSCRYoY
-0.87-48.17%
-1.68-92.83%
-23.43-1.60%
-23.81+32.98%
-17.91+152.66%
-7.09-68.26%
-22.33+1,137.91%
-1.80—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

electroCore, Stock analysis

What does electroCore, do? electroCore, Inc. is a medical device company based in Basking Ridge, New Jersey, operating in the Health Care sector. The company focuses on non-invasive vagus nerve stimulation (nVNS) therapy, offering a hand-held device called gammaCore. This device provides non-drug treatment for adults experiencing episodic cluster and migraine pain. electroCore's technology targets primary headaches, including migraine and cluster headache, as well as related chronic conditions such as gastric motility disorders, psychiatric issues, sleep disorders, and pain disorders. The company went public via an IPO on June 22, 2018, and currently employs 83 full-time staff. Its headquarters are located in Basking Ridge, and it operates within the Health Care industry. electroCore's primary product, gammaCore, is designed for non-invasive cervical vagus nerve stimulation, aiming to address neurological, psychiatric, gastroenterological, and respiratory conditions. The company's website is https://www.electrocore.com/. electroCore is listed under the ticker ECOR with ISIN US28531P2020. The firm's commercial stage operations emphasize non-invasive therapeutic solutions without pharmaceutical intervention. electroCore, is one of the most popular companies on Eulerpool.

Frequently Asked Questions about electroCore, stock

Debt Service Coverage Ratio (DSCR) of electroCore, is -0.87 in 2025.

Debt Service Coverage Ratio (DSCR) of electroCore, changed from -1.68 to -0.87, representing a -48.17% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt Service Coverage Ratio (DSCR) electroCore, since 2006 – with annual values, charts, and detailed analysis.

The DSCR measures a company's ability to service its debt obligations from operating income. A ratio above 1.0 indicates sufficient income to cover debt payments.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt Service Coverage Ratio (DSCR)'s electroCore, with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — electroCore,

All Key Metrics — electroCore,